RSS Feeds
Long-Term Medical Care of Testicular Cancer Survivors
- David J. Vaughn, MD;
- Gretchen A. Gignac, MD; and
- Anna T. Meadows, MD
- From the University of Pennsylvania School of Medicine, The Leonard and Madlyn Abramson Family Cancer Research Institute at the University of Pennsylvania Cancer Center, and The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Abstract
Testicular cancer is the most common solid tumor diagnosed in men 20 to 35 years of age. Because of highly effective treatments that may include surgery, chemotherapy, and radiation therapy, most patients become long-term survivors. Health-related issues that confront testicular cancer survivors include the late medical effects of chemotherapy, the late relapse of disease, the development of second cancers, the effect of the disease and treatment on fertility, and the psychosocial consequences. This case-based discussion focuses on the primary care physician's evaluation and management of a long-term survivor of testicular cancer who was previously treated with surgery and chemotherapy.
Article and Author Information
-
Grant Support: In part by an unrestricted grant from the Lance Armstrong Foundation.
-
Requests for Single Reprints: David J. Vaughn, MD, University of Pennsylvania Cancer Center, 16 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104.
-
Current Author Addresses: Dr. Vaughn: University of Pennsylvania Cancer Center, 16 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104.
-
Dr. Gignac: Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104.
-
Dr. Meadows: The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104.
- Copyright ©2004 by the American College of Physicians
Related Clinical Content
